admin

Biologic-based drugs have increasingly dominated the pharmaceutical market

A staggering 39 million people worldwide could succumb to antibiotic-resistant

Pharma 4.0 is a transformative approach in drug manufacturing, promising to revolutionize

As we approach the fourth quarter of 2024, the global bio/pharma sector

As the pharmaceutical industry evolves and faces greater complexities

The future of the antibiotic pipeline in the pharmaceutical industry

Cell and gene therapies represent an emerging frontier in bio/pharmaceutical

The World Health Organization (WHO) has declared the recent

In the ever-evolving world of global supply chains, certain companies

Contract Development and Manufacturing Organizations (CDMOs)